Journal of Peking University(Health Sciences) ›› 2017, Vol. 49 ›› Issue (5): 749-752. doi: 10.3969/j.issn.1671-167X.2017.05.001
• Article • Next Articles
CLC Number:
| [1] 江载芳, 申昆玲, 沈颖. 诸福棠实用儿科学[M] . 8版. 北京: 人民卫生出版社, 2015: 778-788. [2] Burns JC, Glode MP. Kawasaki syndrome [J]. Lancet, 2004, 364(9433): 533-544. [3] Patel RM, Shulman ST. Kawasaki disease: A comprehensive review of treatment options [J]. J Clin Pharm Ther, 2015, 40(6): 620-625. [4] McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association [J]. Circulation, 2017, 135(17): e927-e999. [5] Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association [J]. Circulation, 2004, 110(17): 2747-2771. [6] Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome [J]. N Engl J Med, 1991, 324(23): 1633-1639. [7] Burns JC, Capparelli EV, Brown JA, et al. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease [J]. Pediatr Infect Dis J, 1998, 17(12): 1144-1148. [8] Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease [J]. Circulation, 2006, 113(22): 2606-2612. [9] Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease [J]. J Pediatr, 2006, 149(2): 237-240. [10] Sano T, Kurotobi S, Matsuzaki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment [J]. Eur J Pediatr, 2007, 166(2): 131-137. [11] Sleeper LA, Minich LL, McCrindle BM, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance [J]. J Pediatr, 2011, 158(5): 831-835. [12] Park HM, Lee DW, Hyun MC, et al. Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease [J]. Korean J Pediatr, 2013, 56(2): 75-79. [13] Tremoulet AH, Best BM, Song S, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease [J]. J Pediatr, 2008, 153(1): 117-121. [14] Yoshimura K, Kimata T, Mine K, et al. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease [J]. J Pediatr, 2013, 162(6): 1205-1209. [15] Sato S, Kawashima H, Kashiwagi Y, et al. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients [J]. Int J Rheum Dis, 2013, 16(2): 168-172. [16] 杜忠东, 张永兰, 赵地, 等. 静脉丙种球蛋白无反应性川崎病的治疗及危险因素分析[J]. 中国实用儿科杂志, 2006, 21(10): 738-741. [17] Do YS, Kim KW, Chun JK, et al. Predicting factors for refractory Kawasaki disease [J]. Korean Circ J, 2010, 40(5): 239-242. [18] Kuo HC, Liang CD, Wang CL, et al. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease [J]. Acta Paediatr, 2010, 99(10): 1578-1583. [19] Kim HK, Oh J, Hong YM, et al. Parameters to guide retreatment after initial intravenous immunoglobulin therapy in Kawasaki disease [J]. Korean Circ J, 2011, 41(7): 379-384. [20] Uehara R, Belay ED, Maddox RA, et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan [J]. Pediatr Infect Dis J, 2008, 27(2): 155-160. [21] Lee SM, Lee JB, Go YB, et al. Prediction of resistance to standard intravenous immunoglobulin therapy in Kawasaki disease [J]. Korean Circ J, 2014, 44(6): 415-422. [22] Nomura Y, Masuda K, Yoshinaga M, et al. Patients diagnosed with Kawasaki disease before the fifth day of illness have a higher risk of coronary artery aneurysm [J]. Pediatr Int, 2002, 44(4): 353-357. [23] Fukunishi M, Kikkawa M, Hamana K, et al. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset [J]. J Pediatr, 2000, 137(2): 172-176. [24] Muta H, Ishii M, Egami K, et al. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan [J]. J Pediatr, 2004, 144(4): 496-499. [25] Muta H, Ishii M, Furui J, et al. Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease [J]. Acta Pediatr, 2006, 95(2): 189-193. [26] Fu PP, Du ZD, Pan YS. Novel predictors of intravenous immunoglobulin resistance in chinese children with Kawasaki disease [J]. Pediatr Infect Dis J, 2013, 32(8): E319-E323. [27] Tang YJ, Yan WH, Sun L, et al. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an east China population [J]. Clin Rheumatol, 2016, 35(11): 2771-2776. [28] Durongpisitkul K, Soongswang J, Laohaprasitiporn D, et al. Immunoglobulin failure and retreatment in Kawasaki disease [J]. Pediatr Cardiol, 2003, 24(2): 145-148. [29] Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction [J]. Am J Cardiol, 2010, 106(4): 470-476. [30] Ha KS, Lee J, Jang GY, et al. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease [J]. Am J Cardiol, 2015, 116(2): 301-306. [31] Kawamura Y, Takeshita S, Kanai T, et al. The combined usefulness of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting intravenous immunoglobulin resistance with Kawasaki disease [J]. J Pediatr, 2016, 178: 281-284.e1. [32] Cho HJ, Bak SY, Kim SY, et al. A high neutrophil to lymphocyte ratio is associated with refractory Kawasaki disease [J]. Pediatr Int, 2017, 59(6): 669-674. [33] Cho KH, Kang SJ. Clinically useful predictors of resistance to intravenous immunoglobulin and prognosis of coronary artery lesions in patients with incomplete Kawasaki disease [J]. Korean Circ J, 2014, 44(5): 328-335. [34] Nakamura Y, Yashiro M, Uehara R, et al. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease [J]. Pediatr Int, 2004, 46(1): 33-38. [35] Aoyagi R, Hamada H, Sato Y, et al. Study protocol for a phase Ⅲ multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin a in patients with severe Kawasaki disease (KAICA trial) [J]. BMJ Open, 2015, 5(12): e009562. [36] 胡坚. 川崎病急性期治疗进展[J]. 中国实用儿科杂志, 2015, 30(1): 1-4. |
| [1] | Chun-yan TAO,Hong-xia LI,Xue-ying LI,Chao-shu TANG,Hong-fang JIN,Jun-bao DU. Hemodynamic changes in standing-up test of children and adolescents with postural tachycardia syndrome [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 414-421. |
| [2] | Fan LI,Han-bin WANG,Qing PENG,Yun-chuang SUN,Ran ZHANG,Bo PANG,Jing FANG,Jue ZHANG,Yi-ning HUANG. Prediction of syncope with nonlinear dynamic analysis during head-up tilt in vasovagal syncope patients [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 430-438. |
| [3] | . [J]. Journal of Peking University(Health Sciences), 0, (): 749-752. |
| [4] | XU Wen-rui, LIAO Ying, JIN Hong-fang, ZHANG Qing-you, TANG Chao-shu, DU Jun-bao. Progress in diagnosis and management of syncope in children [J]. Journal of Peking University(Health Sciences), 0, (): 756-759. |
| [5] | LIAO Ying, ZHANG Qing-you, LI Hong-xia, WANG Yu-li, LIU Ping, DU Jun-bao. Co-morbidity of vasovagal syncope and postural tachycardia syndrome with allergic diseases in children#br# [J]. Journal of Peking University(Health Sciences), 0, (): 783-788. |
| [6] | XU Wen-rui, LIAO Ying, JIN Hong-fang, ZHANG Qing-you, TANG Chao-shu, DU Jun-bao. Progress in diagnosis and management of syncope in children [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 756-759. |
| [7] | LIAO Ying, ZHANG Qing-you, LI Hong-xia, WANG Yu-li, LIU Ping, DU Jun-bao. Co-morbidity of vasovagal syncope and postural tachycardia syndrome with allergic diseases in children [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 783-788. |
| [8] | QU Yan-Ji, LIU Xiao-Qing, MAI Jin-Zhuang, NIE Zhi-Qiang, 欧Yan-Qiu , GAO Xiang-Min, WU Yong, CHEN Ji-Mei. Analysis of environmental risk factors in congenital heart defects [J]. Journal of Peking University(Health Sciences), 2015, 47(3): 420-430. |
|